Clinical Trial: Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07630103) titled 'Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer' on June 01.

Brief Summary: This study is a prospective, open-label, multicenter, randomized, parallel Phase II clinical trial. This study aims to investigate the efficacy and safety of trastuzumab rezetecan or trastuzumab deruxtecan in HER2 positive advanced/metastastic breast cancer

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Advanced Breast Cancer

Intervention: DRUG: Trastuzumab Rezetecan for Injection (SHR-A1811)

SHR-A1811 4.8mg/kg iv q3w

DRUG: Trastuzumab Deruxtecan for Injection (T-DXd)

T-DXd 5.4mg/kg...